Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection
D. R. VanDevanter (Lead / Corresponding author), I. Gonda, J. Dahms, D. Cipolla, A. M. Davis, J. D. Chalmers, J. Froehlich
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection'. Together they form a unique fingerprint.